
1. J Neurol Sci. 2021 Nov 15;430:120034. doi: 10.1016/j.jns.2021.120034. Epub 2021
Oct 19.

Insight in booster COVID-19 vaccine and disease modifying therapy in multiple
sclerosis.

Beard K(1), Sriwastava S(2).

Author information: 
(1)School of Medicine, West Virginia University, United States of America;
Department of Neurology, Rockefeller Neuroscience Institute, West Virginia
University, Morgantown, WV, United States of America.
(2)School of Medicine, West Virginia University, United States of America;
Department of Neurology, Rockefeller Neuroscience Institute, West Virginia
University, Morgantown, WV, United States of America; West Virginia Clinical and 
Translational Science Institute, United States of America. Electronic address:
shitiz.sriwastava@hsc.wvu.edu.

DOI: 10.1016/j.jns.2021.120034 
PMCID: PMC8523307
PMID: 34688988  [Indexed for MEDLINE]

